$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq

$aktsq Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000121390024097800 Filed on November 14, 2024

Income Statement

Concept	2024 Q3
Revenue	$9.027M
YoY Change	28.92%
Cost Of Revenue	$4.725M
YoY Change	-41.57%
Gross Profit	$4.302M
YoY Change	-496.86%
Gross Profit Margin	47.66%
Selling, General & Admin	$6.944M
YoY Change	-32.08%
% of Gross Profit	161.41%
Research & Development	$2.694M
YoY Change	-73.96%
% of Gross Profit	62.62%
Depreciation & Amortization	$500.0K
YoY Change	-79.17%
% of Gross Profit	11.62%
Operating Expenses	$9.638M
YoY Change	-53.15%
Operating Profit	-$5.336M
YoY Change	-75.36%
Interest Expense	-$713.0K
YoY Change	-146.6%
% of Operating Profit
Other Income/Expense, Net	-$1.083M
YoY Change	-170.97%
Pretax Income	-$6.419M
YoY Change	-68.11%
Income Tax	$1.000K
% Of Pretax Income
Net Earnings	-$6.420M
YoY Change	-68.11%
Net Earnings / Revenue	-71.12%
Basic Earnings Per Share	-$0.04
Diluted Earnings Per Share	-$0.04
COMMON SHARES
Basic Shares Outstanding	154.4M shares
Diluted Shares Outstanding	154.4M shares

Balance Sheet

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$12.06M
YoY Change	-53.25%
Cash & Equivalents	$12.10M
Short-Term Investments
Other Short-Term Assets	$3.449M
YoY Change	29.08%
Inventory	$3.168M
Prepaid Expenses
Receivables	$3.832M
Other Receivables	$3.197M
Total Short-Term Assets	$25.71M
YoY Change	-33.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.37M
YoY Change	-78.72%
Goodwill	$6.500M
YoY Change	-55.48%
Intangibles	$11.91M
YoY Change	-18.04%
Long-Term Investments
YoY Change
Other Assets	$71.00K
YoY Change	-2.74%
Total Long-Term Assets	$31.66M
YoY Change	-64.25%
TOTAL ASSETS
Total Short-Term Assets	$25.71M
Total Long-Term Assets	$31.66M
Total Assets	$57.37M
YoY Change	-54.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.698M
YoY Change	-71.81%
Accrued Expenses	$14.13M
YoY Change	1119.15%
Deferred Revenue	$301.0K
YoY Change	1104.0%
Short-Term Debt	$6.219M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$80.09M
YoY Change	403.81%
LONG-TERM LIABILITIES
Long-Term Debt	$42.05M
YoY Change	-1.05%
Other Long-Term Liabilities	$117.0K
YoY Change	-88.3%
Total Long-Term Liabilities	$42.50M
YoY Change	-2.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$80.09M
Total Long-Term Liabilities	$42.50M
Total Liabilities	$122.6M
YoY Change	106.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$444.9M
YoY Change	53.06%
Common Stock	$154.0K
YoY Change	113.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$65.22M
YoY Change
Total Liabilities & Shareholders Equity	$57.37M
YoY Change	-54.88%

Cashflow Statement

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	-$6.420M
YoY Change	-68.11%
Depreciation, Depletion And Amortization	$500.0K
YoY Change	-79.17%
Cash From Operating Activities	-$12.20M
YoY Change	-6.92%
INVESTING ACTIVITIES
Capital Expenditures	$185.0K
YoY Change	-95.6%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$185.0K
YoY Change	-95.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities	-$12.20M
Cash From Investing Activities	-$185.0K
Cash From Financing Activities
Net Change In Cash	-$12.39M
YoY Change	-28.47%
FREE CASH FLOW
Cash From Operating Activities	-$12.20M
Capital Expenditures	$185.0K
Free Cash Flow	-$12.39M
YoY Change	-28.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2024Q3	dei	Entity File Number EntityFileNumber	001-38029
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	AKOUSTIS TECHNOLOGIES, INC.
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-1229046
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	9805 Northcross Center Court
CY2024Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Huntersville
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	28078
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value
CY2024Q3	dei	Trading Symbol TradingSymbol	AKTS
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	154590918	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12061000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24447000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	473000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	294000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3832000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3911000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	3168000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2223000	usd
CY2024Q3	akts	Investment Tax Credit Receivable InvestmentTaxCreditReceivable	3197000	usd
CY2024Q2	akts	Investment Tax Credit Receivable InvestmentTaxCreditReceivable	3197000	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	3449000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	2991000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	25707000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	36769000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12372000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12905000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	6508000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	6508000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11910000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12565000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	803000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	923000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	71000	usd
CY2024Q3	us-gaap	Assets Assets	57371000	usd
CY2024Q2	us-gaap	Assets Assets	69741000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	15303000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	16352000	usd
CY2024Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	57738000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	57372000	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	6219000	usd
CY2024Q2	us-gaap	Notes Payable Current NotesPayableCurrent	10000000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	301000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	131000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	525000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	514000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	80086000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	84369000	usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	42054000	usd
CY2024Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	41887000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	329000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	462000	usd
CY2024Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	117000	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	117000	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	42500000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	42466000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	122586000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	126835000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	175000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	154590918	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	154590918	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123392181	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123392181	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	154000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	123000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	379557000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	381289000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-444926000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-438506000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-65215000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-57094000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57371000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69741000	usd
CY2024Q3	us-gaap	Revenues Revenues	9027000	usd
CY2023Q3	us-gaap	Revenues Revenues	7002000	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	4725000	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	8086000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	4302000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	-1084000	usd
CY2024Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2694000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10346000	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6944000	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10224000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	9638000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	20570000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5336000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-21654000	usd
CY2024Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-713000	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-485000	usd
CY2024Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-366000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2014000	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1083000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1526000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6419000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20128000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-6420000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-20129000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	154426333	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	154426333	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72306689	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72306689	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	-57094000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	-1701000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-6420000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	-65215000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	86239000	usd
CY2023Q3	akts	Cumulative Effect Period Of Adoption Adjustment CumulativeEffectPeriodOfAdoptionAdjustment	-201000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1883000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-20129000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	67792000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-6420000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-20129000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1195000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3017000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	-1701000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1883000	usd
CY2024Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	167000	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	155000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	120000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	113000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-2014000	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-66000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4035000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-610000	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	945000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1366000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	457000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1765000	usd
CY2024Q3	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	333000	usd
CY2023Q3	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	333000	usd
CY2024Q3	akts	Increase Decrease In Litigation Related Contingent Liability IncreaseDecreaseInLitigationRelatedContingentLiability	366000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-872000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-380000	usd
CY2024Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-122000	usd
CY2023Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-101000	usd
CY2024Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	170000	usd
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	208000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12201000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13108000	usd
CY2024Q3	akts	Proceedfromrepayment For Property Plant And Equipment ProceedfromrepaymentForPropertyPlantAndEquipment	185000	usd
CY2023Q3	akts	Proceedfromrepayment For Property Plant And Equipment ProceedfromrepaymentForPropertyPlantAndEquipment	4209000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-185000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4209000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12386000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-17317000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24447000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	43104000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12061000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25787000	usd
CY2024Q3	akts	Accounts Receivable Applied Against Notes Payable AccountsReceivableAppliedAgainstNotesPayable	4114000	usd
CY2024Q3	akts	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	178000	usd
CY2023Q3	akts	Fixed Assets Included In Accounts Payable And Accrued Expenses FixedAssetsIncludedInAccountsPayableAndAccruedExpenses	850000	usd
CY2024Q3	us-gaap	Nature Of Operations NatureOfOperations	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Note 1. Organization</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Akoustis Technologies, Inc. (the “Company”) was incorporated on April 10, 2013, and effective December 15, 2016, the Company changed its state of incorporation to the State of Delaware. Through its wholly-owned subsidiary, Akoustis, Inc. (a Delaware corporation), the Company, headquartered in Huntersville, North Carolina, is focused on developing, designing, and manufacturing innovative radio frequency (“RF”) filter products for the wireless industry, including for products such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi Customer Premise Equipment (“CPE”), and military and defense communication applications. Located between the device’s antenna and its digital backend, the RF front-end (“RFFE”) is the circuitry that performs the analog signal processing and contains components such as amplifiers, filters and switches. To construct the resonator devices that are the building blocks for its RF filters, the Company has developed a family of novel, high purity acoustic piezoelectric materials as well as a unique microelectromechanical system (“MEMS”) wafer semiconductor process, collectively referred to as XBAW® technology. The Company leverages its integrated device manufacturing (“IDM”) and recently introduced foundry business model to develop and sell high performance RF filters using its XBAW® technology. Filters are critical in selecting and rejecting signals, and their performance enables differentiation in the modules defining the RFFE. Additionally, through RFM Integrated Device, Inc. (“RFMi”), a wholly-owned subsidiary of Akoustis, Inc., the Company makes sales of complementary surface acoustic wave (“SAW”) resonators, RF filters, crystal (Xtal) resonators and oscillators, and ceramic products branded as “RFMi” products. The Company also offers back-end semiconductor supply chain services through its wholly owned subsidiary, Grinding & Dicing Services, Inc. (“GDSI"), which it acquired in January 2023.</p>
CY2024Q3	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2013-04-10
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12100000	usd
CY2024Q3	akts	Working Capital WorkingCapital	54400000	usd
CY2024Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	38600000	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	19	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	19	usd
CY2024Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration:underline">Significant Accounting Policies and Estimates</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s significant accounting policies are disclosed in Note. 3 Summary of Significant Accounting Policies in the 2024 Annual Report. Since the date of the 2024 Annual Report, there have been no material changes to the Company’s significant accounting policies. The preparation of the unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and the accompanying notes thereto. The policies, estimates and assumptions include valuing equity securities, derivative liabilities, deferred taxes and related valuation allowances, contingent consideration, goodwill, intangible assets, revenue recognition, and the fair values of long-lived assets. Actual results could differ from the estimates.</p>
CY2024Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9027000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7002000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	131000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	1200000	usd
CY2024Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	300000	usd
CY2024Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1376000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	1591000	usd
CY2024Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1535000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	312000	usd
CY2024Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	257000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	320000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	3168000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	2223000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13556000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13550000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1184000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	645000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12372000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12905000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	500000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	2400000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	6500000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	6500000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1698000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3998000	usd
CY2024Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2093000	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2080000	usd
CY2024Q3	akts	Accrued Goods Received Not Invoiced Current AccruedGoodsReceivedNotInvoicedCurrent	1211000	usd
CY2024Q2	akts	Accrued Goods Received Not Invoiced Current AccruedGoodsReceivedNotInvoicedCurrent	618000	usd
CY2024Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8582000	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8737000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1719000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	919000	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	15303000	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	16352000	usd
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	44000000	usd
CY2024Q3	akts	Debt Discount DebtDiscount	-1947000	usd
CY2024Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1000	usd
CY2024Q3	akts	Carrying Value Of Convertible Notes CarryingValueOfConvertibleNotes	42054000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	44000000	usd
CY2024Q2	akts	Debt Discount DebtDiscount	-2114000	usd
CY2024Q2	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	1000	usd
CY2024Q2	akts	Carrying Value Of Convertible Notes CarryingValueOfConvertibleNotes	41887000	usd
CY2024Q2	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	8000000	usd
CY2024Q2	akts	Sales Agreement SalesAgreement	21000000	usd
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.07
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-1701000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1883000	usd
CY2023Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	1
CY2024Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.1
CY2024Q3	us-gaap	Stockholders Equity Average Amount Outstanding StockholdersEquityAverageAmountOutstanding	2500000	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	148000	usd
CY2023Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	156000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	803000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	923000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	525000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	514000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	329000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	462000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y21D
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y1M13D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1305	pure
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1298	pure
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	455000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	374000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	66000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	68000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	11000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	974000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	120000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	854000	usd
CY2018Q1	us-gaap	Area Of Land AreaOfLand	9.995	acre
CY2018Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	12000000	usd
CY2024Q3	akts	Benefits Of Contingencies BenefitsOfContingencies	400000	usd
CY2024Q2	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	38600000	usd
CY2024Q2	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	57400000	usd
CY2024Q3	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	57700000	usd
CY2024Q3	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	100000	usd
CY2024	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	100000	usd
CY2024Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11337579	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12464962	shares
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	City Area Code CityAreaCode	1-704
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	997-5735
CY2023Q3	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement		usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan		usd
CY2024Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2023Q3	akts	Increase Decrease In Litigation Related Contingent Liability IncreaseDecreaseInLitigationRelatedContingentLiability		usd
CY2024Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q3	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q3	akts	Accounts Receivable Applied Against Notes Payable AccountsReceivableAppliedAgainstNotesPayable		usd
CY2024Q3	dei	Amendment Flag AmendmentFlag	false
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001584754

Files In Submission

Name	View Source	Status
0001213900-24-097800-index-headers.html	Edgar Link	pending
0001213900-24-097800-index.html	Edgar Link	pending
0001213900-24-097800.txt	Edgar Link	pending
0001213900-24-097800-xbrl.zip	Edgar Link	pending
akts-20240930.xsd	Edgar Link	pending
ea0218907-10q_akoustis.htm	Edgar Link	pending
ea021890701ex10-1_akoustis.htm	Edgar Link	pending
ea021890701ex31-1_akoustis.htm	Edgar Link	pending
ea021890701ex31-2_akoustis.htm	Edgar Link	pending
ea021890701ex32-1_akoustis.htm	Edgar Link	pending
ea021890701ex32-2_akoustis.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
akts-20240930_def.xml	Edgar Link	unprocessable
akts-20240930_pre.xml	Edgar Link	unprocessable
akts-20240930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0218907-10q_akoustis_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
akts-20240930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq

2024 Q3 Form 10-Q Financial Statement

#000121390024097800 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKTSQ Akoustis Technologies, Inc. Stock $aktsq

2024 Q3 Form 10-Q Financial Statement

#000121390024097800 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AKTSQ
Akoustis Technologies, Inc. Stock $aktsq